Clinical Trials Browser

Recurrence × TPI-287 × Clear all

NCT00867568 2024-08-06

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

Phase 1 Completed

18 enrolled 12 charts

Medulloblastoma, Neuroblastoma, Recurrence

NCT01340729 2013-04-05

Open-Label Study of TPI 287 for Patients With Metastatic Melanoma

Phase 1/2 Withdrawn

Melanoma, Recurrence, Disease Progression